4.6 Article

A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment

期刊

PLOS ONE
卷 8, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0066316

关键词

-

资金

  1. Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative
  2. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [AI093772, AI087782, AI105170]

向作者/读者索取更多资源

Oral immunization using whole inactivated influenza virus vaccine promises an efficient vaccination strategy. While oral vaccination was hampered by harsh gastric environment, a systematic understanding about vaccine destabilization mechanisms was not performed. Here, we investigated the separate and combined effects of temperature, retention time, pH, and osmotic stress on the stability of influenza vaccine by monitoring the time-dependent morphological change using stopped-flow light scattering. When exposed to osmotic stress, clustering of vaccine particles was enhanced in an acidic medium (pH 2.0) at >= 25 degrees C. Fluorescence spectroscopic studies showed that hyper-osmotic stress at pH 2.0 and 37 degrees C caused a considerable increase in conformational change of antigenic proteins compared to that in acidic iso-osmotic medium. A structural integrity of membrane was destroyed upon exposure to hyper-osmotic stress, leading to irreversible morphological change, as observed by undulation in stopped-flow light scattering intensity and transmission electron microscopy. Consistent with these analyses, hemagglutination activity decreased more significantly with an increasing magnitude of hyper-osmotic stress than in the presence of the hypo- and iso-osmotic stresses. This study shows that the magnitude and direction of the osmotic gradient has a substantial impact on the stability of orally administrated influenza vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Isothermal amplification using sequence-specific fluorescence detection of SARS coronavirus 2 and variants in nasal swabs

Les Jones, Hemant K. Naikare, Yung-Yi C. Mosley, Ralph A. Tripp

Summary: The study aimed to develop a rapid and sensitive nucleic acid amplification assay for the detection of the novel coronavirus and its variants. The researchers successfully designed a fluorescence-quenched reverse transcription loop-mediated isothermal amplification method, which can detect the virus in clinical samples within a short time and has high sensitivity and specificity.

BIOTECHNIQUES (2022)

Review Virology

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

Ralph A. Tripp, David E. Martin

Summary: Viral replication and transmissibility are the main causes of endemic and pandemic disease threats. Broad-spectrum antiviral agents are needed. The most common respiratory viruses are coronaviruses, respiratory syncytial viruses, and influenza viruses. Probenecid has been shown to be safe and effective in limiting the replication of influenza A virus and SARS-CoV-2, as well as inhibiting RSV replication in vitro and in vivo.

VIRUSES-BASEL (2022)

Article Virology

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

Jackelyn Murray, Harrison C. Bergeron, Les P. Jones, Zachary Beau Reener, David E. Martin, Fred D. Sancilio, Ralph A. Tripp

Summary: This study investigated the prophylactic and therapeutic efficacy of probenecid, an FDA-approved drug, in inhibiting RSV replication. The results showed that nanomolar concentrations of probenecid prevented RSV replication in vitro and in vivo, suggesting its potential as a prophylactic and chemotherapeutic agent for RSV.

VIRUSES-BASEL (2022)

Article Chemistry, Medicinal

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses

Brendan T. Freitas, Daniil A. Ahiadorme, Rahul S. Bagul, Ian A. Durie, Samir Ghosh, Jarvis Hill, Naomi E. Kramer, Jackelyn Murray, Brady M. O'Boyle, Emmanuel Onobun, Michael G. Pirrone, Justin D. Shepard, Suzanne Enos, Yagya P. Subedi, Kapil Upadhyaya, Ralph A. Tripp, Brian S. Cummings, David Crich, Scott D. Pegan

Summary: In the past 20 years, both severe acute respiratory syndrome coronavirus-1 and severe acute respiratory syndrome coronavirus-2 have caused zoonotic outbreaks in humans. The PLpro enzyme from a subgroup 2b bat coronavirus has been studied to identify structural features and substrate specificity. Based on this, 30 novel noncovalent inhibitors for subgroup 2b PLpro enzymes were designed, providing new directions for antiviral development against this group of coronaviruses.

ACS INFECTIOUS DISEASES (2022)

Article Immunology

The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice

Nuha Milad Ashtiwi, Demba Sarr, Tamas Nagy, Z. Beau Reneer, Ralph A. Tripp, Balazs Rada

Summary: The combination treatment of OSCN- and AMT shows potential in curing lethal influenza virus infection. Monotherapy with OSCN- or AMT alone does not substantially improve survival outcomes, but the combination treatment significantly inhibits viral replication.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus

Avik Banerjee, Jiachen Huang, Scott A. Rush, Jackelyn Murray, Aaron D. Gingerich, Fredejah Royer, Ching-Lin Hsieh, Ralph A. Tripp, Jason S. McLellan, Jarrod J. Mousa

Summary: This study identified immunodominant antigenic epitopes on the hMPV F protein and identified a monoclonal antibody (mAb) therapy for hMPV F disease prevention and treatment. Additionally, a prefusion-specific epitope on the hMPV F protein was discovered.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Virology

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, Ana M. Nunez M. Castrejon, Rebecca M. DuBois, Larry J. Anderson, Lawrence M. Kauvar, Ralph A. Tripp

Summary: Respiratory syncytial virus (RSV) causes respiratory disease in infants and elderly. Current immune prophylaxis is limited to anti-RSV fusion (F) protein monoclonal antibody (mAb). However, mAbs targeting the attachment (G) protein are necessary to prevent aberrant pathogenic responses. Two high-affinity anti-G protein mAbs, 3D3 and 2D10, have been identified as effective in neutralizing RSV and reducing disease. This study compares the neutralization and immune responses of 3D3, 2D10, and palivizumab in a mouse model of RSV infection.

VIRUSES-BASEL (2023)

Article Chemistry, Multidisciplinary

Highly Effective Salt-Activated Alcohol-Based Disinfectants with Enhanced Antimicrobial Activity

Euna Oh, Seung Joon Choi, Sumin Han, Kyu Hyoung Lee, Hyo-Jick Choi

Summary: This study aims to improve the efficiency of alcohol-based disinfectants by adding a physical pathogen inactivation mechanism through salt recrystallization, preventing the emergence of alcohol tolerance. The experiment showed that additional salt crystallization facilitated stronger biocidal effects compared to alcohol-only formulations, regardless of the types of solid surfaces and pathogens.

ACS NANO (2023)

Review Immunology

Understanding immunity to influenza: implications for future vaccine development

Ralph A. Tripp

Summary: Influenza virus constantly changes, making it difficult to develop immunity through vaccination. Efforts are being made to develop universal vaccines that can protect against various strains of influenza viruses. Understanding the host immune response is crucial for vaccine development.

EXPERT REVIEW OF VACCINES (2023)

Article Virology

Oral Probenecid for Nonhospitalized Adults with Symptomatic Mild-to-Moderate COVID-19

David E. Martin, Neelam Pandey, Purvi Chavda, Gurpreet Singh, Rakesh Sutariya, Frederic Sancilio, Ralph A. Tripp

Summary: This study suggests that treating symptomatic mild-to-moderate COVID-19 patients with probenecid can significantly decrease the time to viral clearance and result in a higher proportion of complete symptom resolution by day 10.

VIRUSES-BASEL (2023)

Review Pharmacology & Pharmacy

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants

Sumin Han, Panjae Lee, Hyo-Jick Choi

Summary: Non-invasive vaccines have gained attention due to the limitations of conventional invasive vaccines. Various approaches for formulating and administrating non-invasive vaccines have emerged, but each faces challenges associated with vaccine bioavailability, toxicity, and other issues. Researchers have developed novel supplementary materials and delivery systems to overcome these limitations and this review article aims to provide up-to-date information and guide future research and development efforts in vaccine formulation for non-invasive vaccines.

PHARMACEUTICS (2023)

Review Microbiology

Interferons-Implications in the Immune Response to Respiratory Viruses

Harrison C. Bergeron, Matthew R. Hansen, Ralph A. Tripp

Summary: This review examines the roles and functions of type I, II, and III IFN responses to respiratory virus infections, as well as the specific IFN responses underlying immunity and protection from disease.

MICROORGANISMS (2023)

Article Infectious Diseases

Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response

Harrison C. Bergeron, Lawrence M. Kauvar, Ralph A. Tripp

Summary: This study investigates how monoclonal antibodies against the RSV F and G proteins modify the type I and III IFN responses to RSV infection. The findings reveal that an anti-G protein monoclonal antibody improves the protective early antiviral response, which has important implications for vaccine and therapeutic design. This research provides insights into the role of G protein antibodies in improving IFN responses against RSV disease.

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2023)

Article Virology

Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19

Ralph A. Tripp, David E. Martin

Summary: In the early stages of drug discovery, assays are developed to evaluate the effectiveness of new and known molecular entities, primarily targeting specific features within the virus. However, screening efforts often prioritize finding active antiviral drugs against known viral targets, overlooking drugs that inhibit virus replication by targeting host genes or pathways.

VIRUSES-BASEL (2023)

Article Chemistry, Multidisciplinary

Engineering of Materials for Respiratory Protection: Salt-Coated Antimicrobial Fabrics for Their Application in Respiratory Devices

Sumin Han, Euna Oh, Erin Keltie, Jong Sung Kim, Hyo-Jick Choi

Summary: Developing highly effective and low-cost methods to protect against direct transmission of respiratory diseases is a major challenge during pandemic outbreaks. Current filtration in respirators and masks raises safety concerns. Reusability of masks has gained attention during the COVID-19 pandemic. Our group has developed antimicrobial coating technologies for respiratory devices and focuses on salt-coated polypropylene fibers.

ACCOUNTS OF MATERIALS RESEARCH (2022)

暂无数据